Gene · 3713
Papers3,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ginsenosides repair UVB-induced skin barrier damage in BALB/c hairless mice and HaCaT keratinocytes. | J Ginseng Res | 2022 | 35035244 | PubTator, text mining | PubMed |
| Calcium selective channel TRPV6: Structure, function, and implications in health and disease. | Gene | 2022 | 35031425 | PubTator, text mining | PubMed |
| Engineering in vitro immune-competent tissue models for testing and evaluation of therapeutics. | Adv Drug Deliv Rev | 2022 | 35031388 | PubTator, text mining | PubMed |
| Presence of Uterine Leiomyomas Has No Significant Impact on Gene Expression Profile in the Scalp of Patients with Central Centrifugal Cicatricial Alopecia. | JID Innov | 2022 | 35024684 | PubTator, text mining | PubMed |
| Transglutaminase 3 crosslinks the secreted gel-forming mucus component Mucin-2 and stabilizes the colonic mucus layer. | Nat Commun | 2022 | 35017479 | PubTator, text mining | PubMed |
| Minimally invasive skin sampling and transcriptome analysis using microneedles for skin type biomarker research. | Skin Res Technol | 2022 | 35007372 | PubTator, text mining | PubMed |
| Dihydroartemisinin targets fibroblast growth factor receptor 1 (FGFR1) to inhibit interleukin 17A (IL-17A)-induced hyperproliferation and inflammation of keratinocytes. | Bioengineered | 2022 | 35006038 | PubTator, text mining | PubMed |
| Desmoglein-3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells. | Mol Oncol | 2022 | 35000271 | PubTator, text mining | PubMed |
| MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination. | Cell Mol Immunol | 2022 | 34992275 | PubTator, text mining | PubMed |
| Origin of Allergy From In Utero Exposures to the Postnatal Environment. | Allergy Asthma Immunol Res | 2022 | 34983104 | PubTator, text mining | PubMed |
| A combination of Vitreoscilla filiformis extract and Vichy volcanic mineralizing water strengthens the skin defenses and skin barrier. | J Eur Acad Dermatol Venereol | 2022 | 34979591 | PubTator, text mining | PubMed |
| Establishment of Human Pluripotent Stem Cell-Derived Skin Organoids Enabled Pathophysiological Model of SARS-CoV-2 Infection. | Adv Sci (Weinh) | 2022 | 34971128 | PubTator, text mining | PubMed |
| [Differences of water barrier function between keloid and its surrounding normal skin in patients with keloids and its related mechanism]. | Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi | 2022 | 34954936 | PubTator, text mining | PubMed |
| Mouse Models of Psoriasis: A Comprehensive Review. | J Invest Dermatol | 2022 | 34953514 | PubTator, text mining | PubMed |
| Preclinical evidence for pioglitazone and bexarotene combination in oral cancer chemoprevention. | Head Neck | 2022 | 34931381 | PubTator, text mining | PubMed |
| Effects of amniotic fluid on human keratinocyte gene expression: Implications for wound healing. | Exp Dermatol | 2022 | 34921689 | PubTator, text mining | PubMed |
| Elevated EDAR signalling promotes mammary gland tumourigenesis with squamous metaplasia. | Oncogene | 2022 | 34916592 | PubTator, text mining | PubMed |
| MAB21L4 regulates the TGF-β-induced expression of target genes in epidermal keratinocytes. | J Biochem | 2022 | 34908107 | PubTator, text mining | PubMed |
| Comparison of three different skin substitutes in promoting wound healing in an ovine model. | Burns | 2022 | 34893370 | PubTator, text mining | PubMed |
| Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptome. | Int J Biol Macromol | 2022 | 34826456 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3713/papers?page=36